Mild Cognitive Impairment Clinical Trials in Baltimore, Maryland

7 studies are recruiting for mild cognitive impairment in Baltimore, Maryland right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

1. Determinants of Incident Stroke Cognitive Outcomes and Vascular Effects on RecoverY

   The overall goal of the DISCOVERY study is to better understand what factors contribute to changes in cognitive (i.e., thinking and memory) abilities in patients who experienced a stroke. The purpose of the study is to help doctors identify patients at risk for dementia (decline in memory, thinking…

   Stage

   Not phased

   Ages

   18 and older

   Site

   University of Maryland Medical Center, Baltimore, Maryland

   Locations

   31 in total

   Run by

   Massachusetts General Hospital

   See if you can join NCT04916210 on ClinicalTrials.gov

2. Psilocybin for Depression in People With Mild Cognitive Impairment or Early Alzheimer's Disease

   This open-label pilot study examines whether the hallucinogenic drug, psilocybin, given under supportive conditions, is safe and effective for depression in people with Mild Cognitive Impairment (MCI) or early Alzheimer's Disease (AD). This study will also assess whether psilocybin may improve qual…

   Stage

   EARLY_Phase 1

   Ages

   18 to 85

   Site

   Johns Hopkins Center for Psychedelic and Consciousness Research, Baltimore, Maryland

   Run by

   Johns Hopkins University

   See if you can join NCT04123314 on ClinicalTrials.gov

3. Trial of CORT108297 to Attenuate the Effects of Acute Stress in the Allocortex (CORT-X)

   CORT-X will examine if mitigation of stress-mediated pathogenesis of Alzheimer's disease (AD) is a feasible target for intervention in individuals at risk for this disease. This single-site (Baltimore, Maryland) phase II clinical trial is a 2-week, randomized, placebo-controlled crossover study of …

   Stage

   Phase 2

   Ages

   55 and older

   Site

   Johns Hopkins School of Medicine, Baltimore, Maryland

   Run by

   Johns Hopkins University

   See if you can join NCT04601038 on ClinicalTrials.gov

4. Evaluate the Effect of Atorvastatin on Cerebrovascular Reactivity in Mild Cognitive Impairment (MCI)

   The purpose of this study is to evaluate the effect of atorvastatin on brain vessel reactivity and with it on blood flow in people with mild cognitive impairment.

   Stage

   Phase 2

   Ages

   60 to 95

   Site

   Johns Hopkins University, Bayview Medical Center, Baltimore, Maryland

   Run by

   Johns Hopkins University

   See if you can join NCT04765137 on ClinicalTrials.gov

5. Working Memory and Physical Exercise Training in Patients With Mild Cognitive Impairment

   The prevalence of dementia will double in the next three decades in the U.S.; effective treatment or prevention for dementia is urgently needed. The current exploratory project aims to evaluate and understand how the brain and cognition may improve after a 12-week intervention that combines brain t…

   Stage

   Not phased

   Ages

   50 to 80

   Site

   University of Maryland Baltimore, Baltimore, Maryland

   Run by

   University of Maryland, Baltimore

   See if you can join NCT05948930 on ClinicalTrials.gov

6. Music Therapy for Patients With Alzheimer's Disease

   This study is designed to assess the feasibility that individualized reminiscence-based virtual music therapy sessions can enhance autobiographical memory, mood, and cognition in patients with mild cognitive impairment (MCI) or mild dementia due to Alzheimer's Disease (AD). 60 patients with MCI or …

   Stage

   Not phased

   Ages

   18 to 89

   Site

   Johns Hopkins School of Medicine, Baltimore, Maryland

   Run by

   Johns Hopkins University

   See if you can join NCT05151562 on ClinicalTrials.gov

7. Cognitive Vulnerability to Stress in Individuals at Risk for Alzheimer's Disease

   The goal of this clinical trial is to learn about how genetics and the response to stress predicts cognitive decline in individuals with mild cognitive impairment. The main question[s] it aims to answer are: * Does the hormone response to acute stress predict the degree of cognitive impairment foll…

   Stage

   Not phased

   Ages

   60 and older

   Site

   Johns Hopkins School of Medicine, Baltimore, Maryland

   Run by

   Johns Hopkins University

   See if you can join NCT05795634 on ClinicalTrials.gov